Characteristics and Outcomes of Myelodysplastic Syndrome Patients Treated With Darbepoetin Alfa for Anemia in Turkey: A Multicenter Retrospective Study

被引:0
|
作者
Acar, Ibrahim Halil [1 ]
Atalay, Figen [2 ]
Demirsoy, Esra Terzi [3 ]
Can, Ferda [4 ]
Guven, Zeynep Tugba [5 ]
Cetiner, Mustafa [6 ]
Tombak, Anil [7 ]
Comert, Melda [8 ]
Guvenc, Birol [1 ]
机构
[1] Cukurova Univ, Dept Hematol, Dept Internal Med, Fac Med, Adana, Turkiye
[2] Baskent Univ, Istanbul Hosp, Hematol Clin, Ankara, Turkiye
[3] SBU Kocaeli Derince Training & Res Hosp, Hematol Clin, Kocaeli, Turkiye
[4] Ankara City Hosp, Hematol Clin, Ankara, Turkiye
[5] Erciyes Univ, Dept Hematol, Dept Internal Med, Fac Med, Kayseri, Turkiye
[6] Acibadem Maslak Hosp, Hematol Clin, Istanbul, Turkiye
[7] Mersin Univ, Dept Hematol, Dept Internal Med, Fac Med, Mersin, Turkiye
[8] SBU Gulhane Training & Res Hosp, Hematol Clin, Istanbul, Turkiye
来源
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词
MDS; myelodysplastic syndrome; darbepoetin alfa;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MDS-143
引用
收藏
页码:S354 / S354
页数:1
相关论文
共 50 条
  • [11] Darbepoetin alfa for the treatment of anemia in patients with myelofibrosis with myeloid metaplasia (MMM). Results from a Danish multicenter study
    Hannestad, Kathrine
    Larsen, Thomas Stauffer
    Andersen, Torbert Mourits
    Clausen, Niels Aage Toeffner
    Hansen, Per Boye
    Jensen, Bjarne Anker
    Birgens, Henrik Sverre
    Hasselbalch, Hans Carl
    BLOOD, 2007, 110 (11) : 234B - 234B
  • [12] Peginesatide for Maintenance Treatment of Anemia in Hemodialysis and Nondialysis Patients Previously Treated with Darbepoetin Alfa
    Fishbane, Steven
    Roger, Simon D.
    Martin, Edouard
    Runyan, Grant
    O'Neil, Janet
    Qiu, Ping
    Locatelli, Francesco
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (04): : 538 - 545
  • [13] Inflammatory Arthritis in Patients with Myelodysplastic Syndrome: French Multicenter Retrospective Study
    Mekinian, Arsene
    Decaux, Olivier
    Falgarone, Geraldine
    Braun, Thorsten, Sr.
    Toussirot, Eric
    Raffray, Loic
    Gombert, Bruno
    de Wazieres, Bruno
    Buchdaul, Anne Laure
    Ziza, Jean-Marc
    Launay, David
    Denis, Guillaume
    Madaule, Serge
    Fenaux, Pierre
    Fain, Olivier
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S83 - S84
  • [14] Effectiveness of darbepoetin alfa versus epoetin alfa in patients with chemotherapy-induced anemia treated in clinical practice
    Patton, J
    Reeves, T
    Wallace, J
    ONCOLOGIST, 2004, 9 (04): : 451 - 458
  • [15] Darbepoetin alfa for the treatment of anemia in children undergoing peritoneal dialysis: a multicenter prospective study in Japan
    Hattori, Motoshi
    Matsunaga, Akira
    Akioka, Yuko
    Fujinaga, Shuichiro
    Nagai, Takuhito
    Uemura, Osamu
    Nakakura, Hyogo
    Ashida, Akira
    Kamei, Koichi
    Ito, Shuichi
    Yamada, Takuji
    Goto, Yoshimitsu
    Ohta, Toshiyuki
    Hisano, Masataka
    Komatsu, Yasuhiro
    Itami, Noritomo
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (04) : 582 - 588
  • [16] A randomized, multicenter study of subcutaneous and intravenous darbepoetin alfa for the treatment of chemotherapy-induced anemia
    Justice, G
    Kessler, JF
    Jadeja, J
    Campos, L
    Weick, J
    Chen, CF
    Heatherington, AC
    Amado, RG
    ANNALS OF ONCOLOGY, 2005, 16 (07) : 1192 - 1198
  • [17] Darbepoetin alfa for treating anemia in low-risk myelodysplastic syndrome patients: Interim results after 27/28 weeks.
    Paguette, R.
    Gabrilove, J.
    Lyons, R.
    Mushtaq, C.
    Sekeres, M.
    Lam, H.
    Dreiling, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 352S - 352S
  • [18] EFFICACY AND SAFETY OF DARBEPOETIN ALFA (DA) FOR ANEMIA IN CHILDREN WITH CKD: A MULTICENTER PROSPECTIVE STUDY IN JAPAN
    Hattori, Motoshi
    Uemura, Osamu
    Hataya, Hiroshi
    Ito, Shuichi
    Hisano, Masataka
    Ohta, Toshiyuki
    Fujinaga, Shuichiro
    Kise, Tomoo
    Goto, Yoshimitsu
    Matsunaga, Akira
    Hashimoto, Taeko
    Tsutsumi, Yasushi
    Ito, Naoko
    Akizawa, Tadao
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 521 - 521
  • [19] Darbepoetin alfa for the treatment of anemia in children undergoing peritoneal dialysis: a multicenter prospective study in Japan
    Motoshi Hattori
    Akira Matsunaga
    Yuko Akioka
    Shuichiro Fujinaga
    Takuhito Nagai
    Osamu Uemura
    Hyogo Nakakura
    Akira Ashida
    Koichi Kamei
    Shuichi Ito
    Takuji Yamada
    Yoshimitsu Goto
    Toshiyuki Ohta
    Masataka Hisano
    Yasuhiro Komatsu
    Noritomo Itami
    Clinical and Experimental Nephrology, 2013, 17 : 582 - 588
  • [20] The efficacy and safety of darbepoetin alfa for treating anemia in low-risk myelodysplastic syndrome patients: Results after 53/55 weeks.
    Gabrilove, Janice
    Paquette, Ronald
    Lyons, Roger M.
    Mushtaq, Chaudhry
    Sekeres, Mikkael A.
    Lam, Hung
    Dreiling, Lyndah
    BLOOD, 2006, 108 (11) : 755A - 755A